Correlation Between Immutep and Oncology Pharma
Can any of the company-specific risk be diversified away by investing in both Immutep and Oncology Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immutep and Oncology Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immutep Ltd ADR and Oncology Pharma, you can compare the effects of market volatilities on Immutep and Oncology Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immutep with a short position of Oncology Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immutep and Oncology Pharma.
Diversification Opportunities for Immutep and Oncology Pharma
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Immutep and Oncology is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Immutep Ltd ADR and Oncology Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncology Pharma and Immutep is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immutep Ltd ADR are associated (or correlated) with Oncology Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncology Pharma has no effect on the direction of Immutep i.e., Immutep and Oncology Pharma go up and down completely randomly.
Pair Corralation between Immutep and Oncology Pharma
Given the investment horizon of 90 days Immutep is expected to generate 147.86 times less return on investment than Oncology Pharma. But when comparing it to its historical volatility, Immutep Ltd ADR is 72.31 times less risky than Oncology Pharma. It trades about 0.14 of its potential returns per unit of risk. Oncology Pharma is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest 0.01 in Oncology Pharma on September 2, 2024 and sell it today you would earn a total of 0.00 from holding Oncology Pharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.24% |
| Values | Daily Returns |
Immutep Ltd ADR vs. Oncology Pharma
Performance |
| Timeline |
| Immutep Ltd ADR |
| Oncology Pharma |
Immutep and Oncology Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immutep and Oncology Pharma
The main advantage of trading using opposite Immutep and Oncology Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immutep position performs unexpectedly, Oncology Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncology Pharma will offset losses from the drop in Oncology Pharma's long position.| Immutep vs. Ocean Biomedical | Immutep vs. Elevation Oncology | Immutep vs. Zura Bio Limited | Immutep vs. Cns Pharmaceuticals |
| Oncology Pharma vs. Regen BioPharma | Oncology Pharma vs. Regen BioPharma | Oncology Pharma vs. Therapeutic Solutions International | Oncology Pharma vs. Alpha Cognition |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |